Vaxcyte (PCVX) Payables (2019 - 2026)
Vaxcyte (PCVX) reported Payables of $63.1 million for Q1 2026, up 207.4% year-over-year from $20.5 million in Q1 2025, and down 11.06% quarter-over-quarter from $70.9 million in Q4 2025.
Vaxcyte (PCVX) Payables (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 8 years of Payables data on file, last reported at $63.1 million in Q1 2026.
- Payables for Q1 2026 came in at $63.1 million, up 207.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.1 million (up 207.4% YoY), and the FY2025 annual result was $70.9 million, up 46.34% from the prior year.
- Payables declined to $63.1 million in Q1 2026 per PCVX's latest filing, from $70.9 million in the prior quarter.
- Over five years, Payables peaked at $70.9 million in Q4 2025 and troughed at $4.8 million in Q1 2022.
- A 5-year average of $24.6 million and a median of $16.3 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2024: Payables tumbled 84.93% in 2022, then jumped 232.16% in 2024.
- A 5-year view of Payables shows it stood at $9.8 million in 2022, then jumped by 48.92% to $14.6 million in 2023, then jumped by 232.16% to $48.5 million in 2024, then soared by 46.34% to $70.9 million in 2025, then declined by 11.06% to $63.1 million in 2026.
- Business Quant data shows PCVX's Payables at $63.1 million in Q1 2026, $70.9 million in Q4 2025, and $49.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 34.55 Mn |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | 63.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.06 Mn |
| Dec 31, 2025 | 70.90 Mn |
| Sep 30, 2025 | 48.96 Mn |
| Jun 30, 2025 | 31.41 Mn |
| Mar 31, 2025 | 20.51 Mn |
| Dec 31, 2024 | 48.45 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 10.47 Mn |
| Mar 31, 2024 | 21.72 Mn |
| Dec 31, 2023 | 14.59 Mn |
| Sep 30, 2023 | 15.70 Mn |
| Jun 30, 2023 | 16.27 Mn |
| Mar 31, 2023 | 11.62 Mn |
| Dec 31, 2022 | 9.80 Mn |
| Sep 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 7.04 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 6.76 Mn |
| Sep 30, 2021 | 25.71 Mn |
| Jun 30, 2021 | 23.70 Mn |